ATLANTA–(BUSINESS WIRE)–Genexa, the world’s first clean and over-the-counter pharmaceutical company, has just completed its unprecedented $60 million Series A funding to advance its market leadership in this emerging space. Marking a major development in the consumer healthcare industry, Genexa’s oversubscribed campaign was the biggest Series A ever for an over-the-counter drug company, confirming the dramatic shift in consumers seeking more options. clean. Initially seeking $25 million in capital, Genexa grew the round due to the caliber of investors and celebrities who wanted to be involved in creating a cleaner, more transparent medicine aisle.
“Genexa is at the forefront of a powerful movement that will revolutionize the over-the-counter drug industry for years to come,” notes Brian Perkins, President of Genexa and former Global President of Consumer Pharmaceuticals & Nutritionals at Johnson & Johnson. “In an industry ripe for disruption, Genexa is delivering long-awaited formulation improvements with high-quality ingredients and setting an entirely new standard and level of transparency in over-the-counter medications.”
Jared Steinco-founder and managing partner of capital monogram led the round and was joined by some of the world’s most reputable investors, including Unilever Ventures, Verlinvest, Northcastle Partners, and Capital of King’s Point. Joining this high-profile group of investors was an equally potent roster of celebrity wellness advocates, including Gwyneth Paltrow, Chris Pratt, Catherine Schwarzenegger, Donald Glover, Lily Aldridge, jennifer meyer, Regina Hall, Sanaa Lathan, Don Cheadle, Brigid Coulter, Lana Parilla, Patrick Schwarzenegger, Tony Kanel, Zoey Deutsch, Brandon Shainfeld and Angela Flecher.
“Genexa heralds a sea change in medicine, giving consumers access to the first clean, healthier and effective option ever offered to the OTC market. Consumers have demanded better in every other facet of their lives, and with Genexa, they can finally do the same in their medicine cabinets,” said the co-founder and managing partner of Monogram Capital. Jared Stein. “We couldn’t be more proud to support David and Max’s mission to lead this generational category shift.”
Founded by david johnson and Max Spielbergtwo fathers on a personal mission to find better medicines for their families, Genexa offers cleaner and more effective over-the-counter medicines covering all traditional categories of over-the-counter medicines, including pain and fever, colds and flu , digestion and allergies, with products for infants, children and adults alike.
Genexa’s innovative and patented preservation system has enabled the company to set a new global standard for the industry, becoming the brand of choice for consumers seeking a healthier lifestyle. Genexa products have the same effective active ingredients as category leaders, but for the first time ever, without the unnecessary and potentially harmful fillers found in most other traditional over-the-counter offerings. Their “Ex List”, the list of unnecessary ingredients often found in other brands that will never be found in Genexa formulas, includes sorbitol, propylene glycol, artificial colors, synthetic binders, talc and common allergens like gluten and lactose.
Genexa’s products are available at more than 45,000 retailers nationwide, including Walmart, Target, CVS, Kroger, Target, Walgreens, Whole Foods and Sprouts, as well as online at Genexa.com and Amazon.
Along with pharmaceutical industry veterans like Perkins, the company has assembled a respected Medical Advisory Board of leading experts.
“We did not accept the feedback we received from countless manufacturers who told us that artificial binders and fillers were needed in over-the-counter drugs to keep them stable, so we decided to bring together leading experts medical and industry business minds to create a better solution,” said the co-founders of Genexa Johnson and Spielberg. “Through the innovative products we create and the breakthroughs we have achieved with over-the-counter medications, we hope to inspire others in the industry to continue our mission to clean up the medication aisle and provide solutions. cleaner and healthier for all.”
All of Genexa’s products are manufactured under FDA guidelines and are project verified non-GMO and gluten-free. Many are also certified organic and vegan. As a Certified B-Corporation, Genexa is committed to using business as a force for good, adhering to rigorous standards of social and environmental performance, accountability and transparency.
For more information, visit Genexa.com.
Founded by two fathers on a mission to revolutionize the medicine aisle, Genexa makes medicine with the same active ingredients people need, but without the artificial ingredients they don’t. We believe people deserve better. That’s why our business is built on a commitment to putting people above everything else. All of our products are made to the highest medical standards with no artificial colors, common allergens or unnecessary inactive ingredients. It’s real medicine, made clean. Find out how we put people above all else, in everything we do, at Genexa.com.
ABOUT MONOGRAM CAPITAL:
Based in Los Angeles, California, and founded in 2014, Monogram Capital Partners focuses exclusively on investing in high-growth consumer and omnichannel brands with over $500 million in capital under management. The company seeks to partner with strong founders and management teams, supporting category-leading brands including Chewy.com, Oatly, Country Archer, Olipop, Vive Organic and Foxtrot. Genexa represents the firm’s twenty-eighth portfolio company. To learn more about Monogram, please visit: www.monogramcapital.com.